Ann: Change of Interest of Substantial Holder from PVL, page-66

I think we all land around that 1.4 cash backing level, but remember the doctors & medical staff that run these trials are notoriously expensive , one of the few chances to pay themselves away from the public sector, so need to be very much at the conservative end of where PER lands by the time the trial is fully wound up. So at 1 cent PER is probably around fair value as a shell, by the time Lateral gets control and its drug backdoored in we could be close to $10-12 mill in the bank. More will be revealed about the cash starting point in the appendix 4c cash flow statement next week

Re reading Garners letter to shareholders, we may hear nothing until March (end of Q3), likewise it could take a month or two before any vote is organised to remove Garner/Gittleson, so February looks a deep black hole of nothing . No rush to pay above 0.008 it looks....